Xenotransplantation - Clinical activities and regulatory development

Acta Veterinaria Scandinavica, Supplement

Volumn , Issue 99, 2002, Pages 19-23

  Tibell, Annika ^a   Lundgren, Torbjörn ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BABOON; CELL TRANSPLANTATION; CONFERENCE PAPER; GRAFT REJECTION; HUMAN; LIVER TRANSPLANTATION; NONHUMAN; ORGAN DONOR; PRIMATE; TECHNOLOGY; XENOGRAFT; XENOTRANSPLANTATION;

PAPIO HAMADRYAS; PRIMATES;

EID: 3442878391     PISSN: 00651699     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Bailey LL, Nehlson-Cannarella SL, Concepcion W, Jolley WB: Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 1985, 254, 3321-3329.
2. Bloom ET: Regulating clinical xenotransplantation in the United States. Graft 2001, 4, 160-162.
3. Buchser E, Goddard M, Heyd B, Joseph JM, Favre J, de Tribolet N, Lysaght M, Aebischer P: Immunoisolated xenogenic chromaffin cell therapy for chronic pain. Initial clinical experience. Anesthesiology 1996, 85, 1005-1012; discussion 29A-30A.
4. Fink JS, Schumacher JM, Ellias SL, Palmer EP, Saint-Hilaire M, Shannon K, Penn R, Starr P, VanHorne C, Kott HS, Dempsey PK, Fischman AJ, Raineri R, Manhart C, Dinsmore J, Isacson O: Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results. Cell Transplant. 2000, 9, 273-278.
5. Groth CG, Korsgren O, Tibell A, Tollemar J, Moller E, Bolinder J, Ostman J, Reinholt FP, Hellerstrom C, Andersson A: Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994, 344, 1402-1404.
6. Pascher A, Sauer IM, Hammer C, Gerlach JC, Neuhaus P: Extracorporeal liver perfusion as hepatic assist in acute liver failure: a review of world experience. Xenotransplantation 2002, 9, 309-324.
7. Rosengard AM, Cary NR, Langford GA, Tucker AW, Wallwork J, White DJ: Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. A potential approach for preventing xenograft rejection. Transplantation 1995, 59, 1325-1333.
8. Starzl TE, Fung J, Tzakis A, Todo S, Demetris AJ, Marino IR, Doyle H, Zeevi A. Warty V, Michaels M, et al.: Baboon-to-human liver transplantation. Lancet 1993, 341, 65-71.
9. Tibell A: Regulating clinical xenotransplantation in Europe. Graft 2001, 4, 157-159.
10. Traeger J: Transplantations of kidneys from chimpanzees to man. Primates Med. 1969, 3, 52-54.
11. Zurn AD, Henry H, Schluep M, Aubert V, Winkel L, Eilers B, Bachmann C, Aebischer P: Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells. Cell Transplant. 2000, 9, 471-484.
12. WHO Guidance on Xenogenic Infection/Disease Surveillance and Response: A Strategy for International Cooperation and Coordination. Geneva: WHO, 2001.
13. Animal-to-human transplants: The ethics of xenotransplantation. Nuffield Council of Bioethichs, UK, 1996.
14. Animal tissue into humans: The Advisory Group on the Ethics on Xenotransplantation. Department of Health, London, UK, 1999.